Kenvue

Despite price increases, Haleon's roster of products has largely kept cheaper private-label competition at bay, although the cost-of-living squeeze and com...

Kenvue forecast full-year profit below analysts' expectations after missing quarterly sales estimates, as the Tylenol maker faces sluggish demand in China...

Sanofi has mapped out a separate listing of its consumer healthcare business from the fourth quarter of next year, the French drugmaker said, adding it pla...

Kenvue cut the higher end of its annual profit forecast, as the Benadryl maker saw weakness in demand for its cold and flu medicines and an increased impac...